Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4

REFERENCES

• Devin, A., Cook A., Lin Y., Rodriguez Y., Kelliher M., and Liu Z.. 2000. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12:419–429.
   PubMed Web of Science ®Google Scholar
• Doi, T. S., Takahashi T., Taguchi O., Azuma T., and Obata Y.. 1997. NF-κB relA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953–961.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., May M. J., and Kopp E. B.. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–260.
   PubMed Web of Science ®Google Scholar
• Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18:6867–6874.
   PubMed Web of Science ®Google Scholar
• Kasof, G. M., Prosser J. C., Liu D., Lorenzi M. V., and Gomes B. C.. 2000. The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria. FEBS Lett. 473:285–291.
   PubMedGoogle Scholar
• Kelliher, M. A., Grimm S., Ishida Y., Kuo F., Stanger B. Z., and Leder P.. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8:297–303.
   PubMed Web of Science ®Google Scholar
• Köntgen, F., Grumont R. J., Strasser A., Metcalf D., Li R., Tarlinton D., and Gerondakis S.. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965–1977.
   PubMed Web of Science ®Google Scholar
• Lee, E. G., Boone D. L., Chai S., Libby S. L., Chien M., Lodolce J. P., and Ma A.. 2000. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289:2350–2354.
   PubMed Web of Science ®Google Scholar
• Lewis, M., Tartaglia L. A., Lee A., Bennett G. L., Rice G. C., Wong G. H., Chen E. Y., and Goeddel D. V.. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830–2834.
   PubMed Web of Science ®Google Scholar
• Newton, K., and Dixit V. M.. 2003. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr. Biol. 13:1247–1251.
   PubMed Web of Science ®Google Scholar
• Pazdernik, N. J., Donner D. B., Goebl M. G., and Harrington M. A.. 1999. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-κB. Mol. Cell. Biol. 19:6500–6508.
   PubMedGoogle Scholar
• Pohl, T., Gugasyan R., Grumont R. J., Strasser A., Metcalf D., Tarlinton D., Sha W., Baltimore D., and Gerondakis S.. 2002. The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc. Natl. Acad. Sci. USA 99:4514–4519.
   PubMedGoogle Scholar
• Pomerantz, J. L., Denny E. M., and Baltimore D.. 2002. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J. 21:5184–5194.
   PubMedGoogle Scholar
• Snapper, C. M., Zelazowski P., Rosas F. R., Kehry M. R., Tian M., Baltimore D., and Sha W. C.. 1996. B cells from P50/NF-κ-B knockout mice have selective defects in proliferation, differentiation, germ-line C-H transcription, and Ig class switching. J. Immunol. 156:183–191.
   PubMedGoogle Scholar
• Stanger, B. Z., Leder P., Lee T.-H., Kim E., and Seed B.. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513–523.
   PubMed Web of Science ®Google Scholar
• Sun, S. C., Ganchi P. A., Ballard D. W., and Greene W. C.. 1993. NF-κ B controls expression of inhibitor I κ B α: evidence for an inducible autoregulatory pathway. Science 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Sun, X., Lee J., Navas T., Baldwin D. T., Stewart T. A., and Dixit V. M.. 1999. RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274:16871–16875.
   PubMed Web of Science ®Google Scholar
• Sun, X., Yin J., Starovasnik M. A., Fairbrother W. J., and Dixit V. M.. 2002. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J. Biol. Chem. 277:9505–9511.
   PubMed Web of Science ®Google Scholar
• Takeuchi, O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., and Akira S.. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443–451.
   PubMed Web of Science ®Google Scholar
• Yu, P. W., Huang B. C., Shen M., Quast J., Chan E., Xu X., Nolan G. P., Payan D. G., and Luo Y.. 1999. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr. Biol. 9:539–542.
   PubMedGoogle Scholar
• Zheng, Y., Vig M., Lyons J., Van Parijs L., and Beg A. A.. 2003. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J. Exp. Med. 197:861–874.
   PubMedGoogle Scholar